J INTS BIO
PrivateLast Round
Grant
Jul 2, 2026
Total Funding Raised
$3.91M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
J INTS BIO operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Grant round in July 2026.
J INTS BIO is a biotechnology company that specializes in the development of innovative anti-cancer and orphan drugs, particularly targeted therapies for non-small cell lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
J INTS BIO Comparables
Compare J INTS BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therapex | 94% | |
| RedCloud Bio | 88% | |
| Voronoi | 80% |
For institutional investors. Book with your work email.
J INTS BIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 2, 2026 | ||||
| Series B | Sep 30, 2023 | ||||
| Corporate Funding | Nov 1, 2021 |
For institutional investors. Book with your work email.
J INTS BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anda Asia Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Secured $2.22M in grant funding.
- Nov 1, 2021
Raised $1.69M from Yuhan Corporation
For institutional investors. Book with your work email.
J INTS BIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about J INTS BIO's valuation, stock price, and market status.
Is J INTS BIO a public or private company?
J INTS BIO is a private company.
What is the current stock price of J INTS BIO?
J INTS BIO is a private company, so its shares have no public market price. Caplight tracks J INTS BIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is J INTS BIO worth (valuation)?
Valuation information for J INTS BIO is not publicly available.
Can I buy J INTS BIO stock?
J INTS BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was J INTS BIO's last funding round?
J INTS BIO's most recent funding round was Grant on July 2, 2026.
Who are the main investors in J INTS BIO?
Key investors in J INTS BIO include Anda Asia Ventures.
Will J INTS BIO IPO soon?
No public IPO plans have been announced for J INTS BIO.
How can I track J INTS BIO secondary market activity?
Caplight tracks bids, offers, and trades in J INTS BIO's shares on secondary markets.